---
figid: PMC10203911__etm-25-06-12001-g03
pmcid: PMC10203911
image_filename: PMC10203911__etm-25-06-12001-g03.jpg
figure_link: /pmc/articles/PMC10203911/figure/F4/
number: Figure 4
figure_title: Roflumilast activates the AMPK signaling pathway in MI/R injury.
caption: 'Roflumilast activates the AMPK signaling pathway in MI/R injury. The expression
  of AMPK signaling pathway-associated proteins in myocardial tissue was detected
  by western blotting. ***P<0.001 vs. Control. #P<0.05 and ###P<0.001 vs. MI/R. ++P<0.01
  vs. MI/R + roflumilast (1 mg/kg). AMPK, AMP-activated protein kinase; MI/R, myocardial
  ischemia/reperfusion; p, phosphorylated; SIRT1, sirtuin 1'
article_title: Roflumilast reduces myocardial ischemia reperfusion injury in vivo
  and in vitro by activating the AMPK signaling pathway
citation: Bo Liao, et al. Exp Ther Med. 2023 Jun;25(6).
year: '2023'
pub_date: 2023-6-
epub_date: 2023-5-09
doi: 10.3892/etm.2023.12001
journal_title: Experimental and Therapeutic Medicine
journa_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos
keywords:
- roflumilast
- myocardial ischemia reperfusion injury
- mitochondrial damage
- AMP-activated protein kinase signaling pathway
---
